The nature of pain in complications of the maxillofacial region after COVID-19

Abstract

Background and aimsPatients who have undergone Covid-19 with maxillofacial complications suffer from headaches and local pain for a long time. Purpose: monitoring the clinical course of the nature of pain syndrome in the maxillofacial region of patients with Covid-19. MethodsClinical analysis was carried out on 78 patients who applied to the TMA clinic. The average age of patients was 60 ± 9.0 years, including 41 women (54%) and 37 men (46%), with the diagnosis of cavernous sinus thrombosis, maxillar osteomyelitis 1-3 months after the onset of acute Covid-19 disease. During 1years of rehabilitation, the pain was assessed according to a 10-point criterion (pain load -0 points, very strong -10 points) through the questionnaire. ResultsIn addition to inflammation in these patients, include headache, dizziness, n. Facialis paresis in 39 patients, paresthesia of the 3rd corneal nerve in all patients. In the beginning, severe irradiating headaches were observed in 85% of cases, and in some patients, in the absence of taking non-steroidal anti-inflammatory drugs, the need for narcotic analgesics, sedatives, tranquilizers. During observation, severe pain was in 40% of patients (8-10 points), and in 25% of patients, the average simultaneous pain remained within 3.5 ± 0.18 (p ≥ 0.05). In 15% of patients, the headache persisted up to 4-5 (on average) points. The mean pain score was 3.6 ± 0.13 (p ≥ 0.05) in all patients end of the year. ConclusionsIn patients undergoing COVID 19, thrombosis, facial bone necrosis was very long-term, predominant headaches. In 40% of patients, severe pain persisted for years.